V
Vaxart, Inc. (VXRT)
OQX – Real Time Price. Currency in USD
0.68
+0.03 (4.62%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
OQX – Real Time Price. Currency in USD
0.68
+0.03 (4.62%)
At close: May 12, 2026, 4:00 PM EDT
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company’s product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome coronavirus; Seasonal Influenza vaccine, which is in Phase 2 clinical trial, to treat H1N1 Influenza; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
| Name | Position |
|---|---|
| Dr. James F. Cummings M.D. | Chief Medical Officer |
| Dr. Rajesh Kapoor Ph.D. | Senior Vice President of Quality |
| Dr. Sean N. Tucker Ph.D. | Senior VP & Chief Scientific Officer |
| Mr. Edward B. Berg | Senior VP & General Counsel |
| Mr. Jeroen Grasman M.B.A. | CFO, Principal Accounting Officer & Principal Financial Officer |
| Mr. Steven Lo | President, CEO & Director |
| Ms. Laurie Hastings | Senior Vice President of Human Resources |
| Ms. Shaily Jaini Garg | Senior Vice President of Clinical Development & Project Management |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | S-1 | vxrt20260502_s1.htm |
| 2026-05-07 | 10-Q | vxrt20260331_10q.htm |
| 2026-04-30 | 10-K/A | vxrt20251231_10ka.htm |
| 2026-04-23 | 8-K | vxrt20260423_8k.htm |
| 2026-04-21 | 8-K | vxrt20260420_8k.htm |
| 2026-04-17 | 8-K | vxrt20260417_8k.htm |
| 2026-04-16 | S-3 | vxrt20260414_s3.htm |
| 2026-03-13 | 10-K | vxrt20251231_10k.htm |
| 2026-03-12 | 8-K | vxrt20260311_8k.htm |
| 2025-12-29 | 8-K | vxrt20251226_8k.htm |